Drug intelligence / Profile preview

acetylcholine

Development stage
Approved
Lead developer
COUR Pharmaceuticals
Modality
Small Molecules
Administration
Ophthalmic, Intraocular
01

Overview

Acetylcholine is a naturally occurring parasympathomimetic neurotransmitter and small molecule that plays a central role in both the peripheral and central nervous systems. In medicine, it is primarily used as an ophthalmic agent to induce rapid miosis (pupil constriction) during eye surgeries such as cataract extraction, penetrating keratoplasty, and iridectomy[1][3]. Its mechanism of action involves acting as an agonist at cholinergic receptors—specifically nicotinic and muscarinic acetylcholine receptors—leading to contraction of the iris sphincter muscle (causing miosis) and ciliary muscle (causing accommodation spasm)[1][3][4]. Acetylcholine acts at neuromuscular junctions to activate muscles, serves as the main neurotransmitter of the parasympathetic nervous system, and modulates functions such as memory, attention, arousal, learning, and voluntary muscle movement in the brain[4][5]. Due to its rapid breakdown by cholinesterases in vivo, its clinical use is limited mainly to intraocular administration for surgical purposes[1].

Brand names
MiocholMiochol-E
Other names
acetylcholine chlorideACh
02

Targets

mAChR (Muscarinic acetylcholine receptors)Nicotinic Acetylcholine Receptor

Beyond the preview

Go deeper on acetylcholine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetylcholine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call